Skip to main content

Peer Review reports

From: Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland

Original Submission
15 Mar 2019 Submitted Original manuscript
1 Apr 2019 Author responded Author comments - André B. Kind
17 Apr 2020 Author responded Author comments - André B. Kind
10 Jun 2019 Reviewed Reviewer Report - Elmar Armin Joura
4 Mar 2020 Reviewed Reviewer Report - Research Square Reviewer 1
Resubmission - Version 2
1 Apr 2019 Submitted Manuscript version 2
28 Apr 2020 Author responded Author comments - André B. Kind
Resubmission - Version 3
28 Apr 2020 Submitted Manuscript version 3
29 Apr 2020 Author responded Author comments - André B. Kind
Resubmission - Version 4
29 Apr 2020 Submitted Manuscript version 4
Publishing
3 May 2020 Editorially accepted
12 May 2020 Article published 10.1186/s12889-020-08840-0

You can find further information about peer review here.

Back to article page
\